Axel Schambach
- Molecular Biology top 0.5%
- Genetics top 0.1%
- Oncology top 0.5%
- Immunology top 0.5%
- Physiology top 2%
- Co-authors
- Christopher BaumMelanie GallaTobias MaetzigMichael MorganUte ModlichDaniela ZychlinskiJens BohneMichael Rothe
- Topics
- Virus-based gene therapy research (157 papers)CRISPR and Genetic Engineering (133 papers)RNA Interference and Gene Delivery (87 papers)
- Cited by
- GeneticsOncologyMolecular Biology
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Axel Schambach
317 papers receiving 13.3k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Molecular Biology 8.4k
- Genetics 4.7k
- Oncology 3.4k
- Immunology 2.5k
- Physiology 1.3k
Countries citing papers authored by Axel Schambach
This map shows the geographic impact of Axel Schambach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Schambach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Schambach more than expected).
Fields of papers citing papers by Axel Schambach
This network shows the impact of papers produced by Axel Schambach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Schambach. The network helps show where Axel Schambach may publish in the future.
Co-authorship network of co-authors of Axel Schambach
This figure shows the co-authorship network connecting the top 25 collaborators of Axel Schambach. A scholar is included among the top collaborators of Axel Schambach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Schambach. Axel Schambach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 3 | |
| 5 | 14 | |
| 6 | 10 | |
| 7 | 13 | |
| 8 | 9 | |
| 9 | 0 | |
| 10 | 13 | |
| 11 | 3 | |
| 12 | 61 | |
| 13 | 2 | |
| 14 | 40 | |
| 15 | 9 | |
| 16 | 190 | |
| 17 | Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applicationsbreakdown → | 196 |
| 18 | 31 | |
| 19 | 16 | |
| 20 | 46 |
About Axel Schambach
Axel Schambach is a scholar working on Genetics, Oncology and Molecular Biology, having authored 332 papers that have together received 13.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (157 papers), CRISPR and Genetic Engineering (133 papers) and RNA Interference and Gene Delivery (87 papers). The work is most often cited by research in Genetics (4.7k citations), Oncology (3.4k citations) and Molecular Biology (8.4k citations). Axel Schambach has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Christopher Baum, Christopher Baum, Melanie Galla, Tobias Maetzig, Michael Morgan, Ute Modlich, Daniela Zychlinski, Jens Bohne, Michael Rothe and Hildegard Büning. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.